EDGAR Filing Documents for 0001193125-17-358179

Form 8-K - Current report:

SEC Accession No. 0001193125-17-358179

Filing Date

2017-12-01

Accepted

2017-12-01 09:16:13

Documents

Period of Report

2017-11-28

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d500891d8k.htm	8-K	46903
2	EX-2.1	d500891dex21.htm	EX-2.1	803706
3	EX-4.1	d500891dex41.htm	EX-4.1	67093
4	EX-4.2	d500891dex42.htm	EX-4.2	56991
5	EX-4.3	d500891dex43.htm	EX-4.3	42830
6	EX-4.4	d500891dex44.htm	EX-4.4	37987
7	EX-10.1	d500891dex101.htm	EX-10.1	168440
	Complete submission text file	0001193125-17-358179.txt		1225467

Mailing Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511

Business Address 300 GEORGE STREET SUITE 301 NEW HAVEN CT 06511 312 767 0291

MELINTA THERAPEUTICS, INC. /NEW/ (Filer) CIK: 0001461993 (see all company filings)